
Eight Sleep has secured $50 million in a new strategic round led by Tether Investments, valuing the company at $1.5 billion. The New York-based sleep technology company will use the capital to accelerate its expansion from sleep optimization into predictive, AI-driven health. The round follows a strong 2025, in which Eight Sleep reached free cash flow positivity, launched three new products, and expanded its commercial reach to 34 countries.
The new funding brings Eight Sleep's total capital raised to more than $310 million. Less than a year ago, the company closed a $100 million round. This latest investment signals growing confidence in Eight Sleep's ability to position its smart mattress system as a serious health platform, not just a sleep gadget.
Eight Sleep operates in a market where consumer health technology is increasingly expected to do more than collect data. Wearables and smart devices have conditioned users to expect real-time insights, but Eight Sleep is betting that the next step is anticipation, not just observation. Its Pod system currently tracks biometrics including sleep stages, heart rate, and heart rate variability, then automatically adjusts mattress temperature and elevation throughout the night.
Two peer-reviewed studies published in the past year give the company's health claims clinical weight. One shows the Pod reduces menopausal hot flashes by 56%. A second demonstrates that, for the first time in any consumer device, the system can restore the body's natural circadian temperature rhythm during sleep, improving cardiovascular recovery markers.
"Sleep was just the beginning," said Matteo Franceschetti, Co-founder and CEO of Eight Sleep. "We've built the most advanced AI-powered health sensing system in the world — one that learns your body better every night and acts on that knowledge. This investment gives us the resources to take that intelligence beyond the bedroom and into every dimension of personal health."
The core of Eight Sleep's next phase is a predictive AI agent, and what it's trying to do is genuinely different from what the Pod does today. Rather than reacting to signals during the night, the system will simulate thousands of possible scenarios, including a warm room, recent exercise, a heavy meal, or elevated stress levels, and optimize the sleep environment before the user even gets into bed.
The models behind this system are trained on more than one billion hours of real-world sleep data, collected from users across 35+ countries. That dataset, proprietary and built over years of product usage, is what makes Eight Sleep's position hard to replicate quickly. Early pilot results from daytime AI-driven guidance are already showing behavioral change: nearly half of participants adjusted their activity timing, caffeine habits, or sleep schedules based on automated recommendations.
Capital from this round will be deployed across three areas. R&D investment will go toward accelerating predictive model development. Clinical trial work will be expanded, including regulatory filings in the United States. And commercial partnerships will deepen in key international markets.
Perhaps the most significant strategic move underway is Eight Sleep's pursuit of FDA clearance. The company has filed with the FDA for sleep apnea detection and mitigation capabilities. If cleared, the Pod would shift from a wellness device into a regulated health product, capable of passively screening and intervening at population scale, every single night.
That transition matters commercially. Regulatory approval changes how the product can be positioned to healthcare providers, insurers, and enterprise wellness programs. It is a long road, but the clinical validation work Eight Sleep has already published suggests the company is building that pathway carefully.
Eight Sleep was founded to bring sleep fitness to a mainstream consumer audience, combining hardware, physiology research, and data science to improve sleep quality and support longer-term health. Its Pod smart mattress system, alongside the Pod Pillow Cover and Thermal Blanket, is now sold in more than 34 countries.
The company has earned a following among professional athletes, executives, and health-focused consumers worldwide. It has been recognized three times on Fast Company's Most Innovative Companies list and twice named to TIME's Best Inventions of the Year.
The round was led by Tether Investments, the investment arm of Tether, the company behind the USDT stablecoin. Paolo Ardoino, CEO of Tether, commented on the rationale: "We believe advanced personalized AI is the perfect pathway to understand and expand human potential. Eight Sleep has the potential to define the future of health tech by building intelligence that learns, scales, and evolves directly with humankind, turning advanced AI into practical, everyday insights and enhancements about core human biology."
Eight Sleep has now raised more than $310 million in total funding. Previous backers include investors from rounds that brought the company to $100 million raised ahead of this latest announcement.


